Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (221-230 of 340) with videos related to

Pageof 34
Sort By:
Journal of Crohn'S & Colitis|March 17, 2026
Distinct hepcidin patterns in Crohn's disease and ulcerative colitis: links to iron homeostasis and inflammatory activityFernando Magro, Paula Ministro, Helena Tavares de Sousa, et al.
United European Gastroenterology Journal|March 6, 2023
Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta-analysisFernando Magro, Paula Leão Moreira, Gaia Catalano, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult PatientsBénédicte Caron, Vipul Jairath, Ferdinando D'Amico, et al.
International Journal of Molecular Sciences|June 2, 2021
Interaction between the Renin-Angiotensin System and Enteric Neurotransmission Contributes to Colonic Dysmotility in the TNBS-Induced Model of ColitisMariana Ferreira-Duarte, Tiago Rodrigues-Pinto, Teresa Sousa, et al.
Journal of Crohn'S & Colitis|September 10, 2022
Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPablo A Olivera, Juan S Lasa, Ignacio Zubiaurre, et al.
Porto Biomedical Journal|April 19, 2021
Impact of montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19): protocol for an investigator-initiated open labeled randomized controlled pragmatic trialMargarida Tavares, Mariana Farraia, Susana Silva, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2017
The who-when-why triangle of CAM use among Portuguese IBD patientsFrancisco Portela, Camila C Dias, Paulo Caldeira, et al.
Inflammatory Bowel Diseases|April 5, 2022
Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical ProgramMarla C Dubinsky, Fernando Magro, Flavio Steinwurz, et al.
Acta Medica Portuguesa|July 31, 2024
Clinical Trials in Portugal: Past and Future. Position Paper from the Colleges of Clinical Pharmacology and Pharmaceutical MedicineFilipa Borges-Carneiro, Miguel Torre Souto, Isabel Silva, et al.
Journal of Crohn'S & Colitis|March 27, 2026
Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's diseasePaula Leão Moreira, Axel Dignass, Maria Manuela Estevinho, et al.
Pageof 34

Showing results (221-230 of 340) with videos related to

Sort By:
Pageof 34
Journal of Crohn'S & Colitis|March 17, 2026
Distinct hepcidin patterns in Crohn's disease and ulcerative colitis: links to iron homeostasis and inflammatory activityFernando Magro, Paula Ministro, Helena Tavares de Sousa, et al.
United European Gastroenterology Journal|March 6, 2023
Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta-analysisFernando Magro, Paula Leão Moreira, Gaia Catalano, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult PatientsBénédicte Caron, Vipul Jairath, Ferdinando D'Amico, et al.
International Journal of Molecular Sciences|June 2, 2021
Interaction between the Renin-Angiotensin System and Enteric Neurotransmission Contributes to Colonic Dysmotility in the TNBS-Induced Model of ColitisMariana Ferreira-Duarte, Tiago Rodrigues-Pinto, Teresa Sousa, et al.
Journal of Crohn'S & Colitis|September 10, 2022
Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPablo A Olivera, Juan S Lasa, Ignacio Zubiaurre, et al.
Porto Biomedical Journal|April 19, 2021
Impact of montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19): protocol for an investigator-initiated open labeled randomized controlled pragmatic trialMargarida Tavares, Mariana Farraia, Susana Silva, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 25, 2017
The who-when-why triangle of CAM use among Portuguese IBD patientsFrancisco Portela, Camila C Dias, Paulo Caldeira, et al.
Inflammatory Bowel Diseases|April 5, 2022
Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical ProgramMarla C Dubinsky, Fernando Magro, Flavio Steinwurz, et al.
Acta Medica Portuguesa|July 31, 2024
Clinical Trials in Portugal: Past and Future. Position Paper from the Colleges of Clinical Pharmacology and Pharmaceutical MedicineFilipa Borges-Carneiro, Miguel Torre Souto, Isabel Silva, et al.
Journal of Crohn'S & Colitis|March 27, 2026
Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's diseasePaula Leão Moreira, Axel Dignass, Maria Manuela Estevinho, et al.
Pageof 34